Animal Models For Studying Angelman Syndrome, A Developmental Brain Disorder

研究天使综合症(一种脑发育障碍)的动物模型

基本信息

  • 批准号:
    7184607
  • 负责人:
  • 金额:
    $ 21.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-15 至 2008-11-30
  • 项目状态:
    已结题

项目摘要

Angelman syndrome is a severe developmental brain disorder characterized by mental retardation, seizures, abnormal gait, hyperactivity, frequent laughter, and other abnormalities. Several lines of evidence strongly implicate the loss of the maternal human Ube3A (hUbe3A) gene in most, if not all, cases of Angelman syndrome. Ube3A encodes the E6-AP ubiqutin E3 ligase whose substrates remain largely unknown. How the loss of UbeSA activity leads to clinical symptoms of Angelman syndrome patients needs further investigation. In the Drosophila genome, the gene CG6190 encodes the Drosophila Ube3A (dUbeSA), a protein highly homologous to hUbeSA at the amino acid level. Therefore, Drosophila offers an excellent model system to dissect the molecular and cellular functions of Ube3A. Here we propose to test the hypothesis that UbeSA is required for the proper formation of neuronal fine structures and for the normal development of neuronal connectivity. The defects in these neurodevelopmental processes may contribute to the pathogenesis of Angelman syndrome. We will generate dUbeSA loss-of-function mutant flies and characterize dUbeSA function in neuronal development. We will also use these mutant flies to identify some evolutionary conserved key substrates of UbeSA ubiquitin ligase that mediate the effects of UbeSA on the brain development and function. These studies will provide important insights into the molecular and cellular mechanisms underlying this devastating developmental brain disorder and into the potential avenues for therapeutic interventions. Gladstone Institute of Neurological Disease, The J. David Gladstone Institutes, San Francisco, CA PHS 398 (Rev. 09/04) Page 2 Form Page 2 3 Principal Investigator/Program Director (Last, First, Middle): Gao, Fen-BiaO KEY
Angelman综合征是一种严重的发育性脑障碍,其特征为智力迟钝、癫痫发作、异常步态、多动、频繁大笑和其他异常。几条证据强烈暗示在大多数(如果不是全部)Angelman综合征病例中母体人类Ube 3A(hUbe 3A)基因的丢失。Ube 3A编码E6-AP泛素E3连接酶,其底物在很大程度上仍然未知。UbeSA活性的丧失如何导致Angelman综合征患者的临床症状需要进一步研究。在果蝇基因组中,基因CG 6190编码果蝇Ube 3A(dUbeSA),其是在氨基酸水平上与hUbeSA高度同源的蛋白质。因此,果蝇提供了一个很好的模型系统来剖析Ube 3A的分子和细胞功能。在这里,我们建议测试的假设,UbeSA是必要的神经元精细结构的正确形成和神经元连接的正常发展。这些神经发育过程中的缺陷可能有助于Angelman综合征的发病机制。我们将产生dUbeSA功能丧失突变果蝇,并表征dUbeSA在神经元发育中的功能。我们还将利用这些突变果蝇来鉴定UbeSA泛素连接酶的一些进化上保守的关键底物,这些底物介导UbeSA对大脑发育和功能的影响。这些研究将为这种破坏性发育性脑障碍的分子和细胞机制以及治疗干预的潜在途径提供重要见解。Gladstone神经疾病研究所,J.大卫格莱斯顿研究所,San弗朗西斯科,CA PHS 398(Rev. 09/04)第2页表格第2页3主要研究者/项目负责人(最后,第一,中间):Gao,Fen-BiaO KEY

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Fen-Biao Gao其他文献

Fen-Biao Gao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Fen-Biao Gao', 18)}}的其他基金

Cryo-EM Analysis of Ribosomal Defects in C9ORF72-Associated Frontotemporal Dementia and ALS
C9ORF72 相关额颞叶痴呆和 ALS 核糖体缺陷的冷冻电镜分析
  • 批准号:
    10752450
  • 财政年份:
    2023
  • 资助金额:
    $ 21.36万
  • 项目类别:
Synaptopathy and Pathogenesis in Frontotemporal Dementia: Role of CYLD
额颞叶痴呆的突触病和发病机制:CYLD 的作用
  • 批准号:
    10680953
  • 财政年份:
    2023
  • 资助金额:
    $ 21.36万
  • 项目类别:
Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1
CHMP2B和TBK1突变导致额颞叶痴呆的发病机制研究
  • 批准号:
    10536397
  • 财政年份:
    2018
  • 资助金额:
    $ 21.36万
  • 项目类别:
Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1
CHMP2B和TBK1突变导致额颞叶痴呆的发病机制研究
  • 批准号:
    10542826
  • 财政年份:
    2018
  • 资助金额:
    $ 21.36万
  • 项目类别:
Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1
CHMP2B和TBK1突变导致额颞叶痴呆的发病机制研究
  • 批准号:
    10059266
  • 财政年份:
    2018
  • 资助金额:
    $ 21.36万
  • 项目类别:
Understanding Frontotemporal Dementia Using Drosophila and iPSC Models
使用果蝇和 iPSC 模型了解额颞叶痴呆
  • 批准号:
    10389678
  • 财政年份:
    2017
  • 资助金额:
    $ 21.36万
  • 项目类别:
Induced Pluripotent Stem Cells and Drosophila Models of C9ORF72-Related FTD/ALS
C9ORF72 相关 FTD/ALS 的诱导多能干细胞和果蝇模型
  • 批准号:
    9888450
  • 财政年份:
    2017
  • 资助金额:
    $ 21.36万
  • 项目类别:
Prefrontal AMPA receptors in FTD Pathogenesis
FTD 发病机制中的前额叶 AMPA 受体
  • 批准号:
    9247259
  • 财政年份:
    2016
  • 资助金额:
    $ 21.36万
  • 项目类别:
Interactions between TDP-43 and microRNA-92 in Drosophila and human neurons
果蝇和人类神经元中 TDP-43 和 microRNA-92 之间的相互作用
  • 批准号:
    8785309
  • 财政年份:
    2014
  • 资助金额:
    $ 21.36万
  • 项目类别:
Frontotemporal Dementia Induced Pluripotent Stem Cell Consortium
额颞叶痴呆诱导的多能干细胞联盟
  • 批准号:
    8506482
  • 财政年份:
    2013
  • 资助金额:
    $ 21.36万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了